Trade ETRA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Electra Therapeutics, Inc. (ETRA) is trading at US$13.92, up 5.06% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$869.64M. Over the past 52 weeks, ETRA has traded between US$13.25 and US$16.00. On Syfe you can trade ETRA with $0 commission and add it to your watchlist.
| Previous close | US$13.25 |
|---|---|
| Market cap | US$869.64M |
| 52-week range | US$13.25 – US$16.00 |
| Volume | 813.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Electra Therapeutics, Inc. (ETRA) stock is trading at US$13.92, +5.06% from the previous close of US$13.25.
The market cap for Electra Therapeutics, Inc. (ETRA) stock is approximately US$869.64M.
The 52-week high for Electra Therapeutics, Inc. (ETRA) stock is US$16.00.
The 52-week low for Electra Therapeutics, Inc. (ETRA) stock is US$13.25.
Electra Therapeutics, Inc. (ETRA) does not currently pay a dividend.
Stay on top of ETRA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
